Oui, le tabagisme peut réduire la production de BMP-7 et nuire à la santé osseuse.
TabagismeSanté osseuse
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéine morphogénétique osseuse de type 7 : Questions médicales les plus fréquentes",
"headline": "Protéine morphogénétique osseuse de type 7 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéine morphogénétique osseuse de type 7 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-18",
"dateModified": "2026-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéine morphogénétique osseuse de type 7"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines morphogénétiques osseuses",
"url": "https://questionsmedicales.fr/mesh/D019485",
"about": {
"@type": "MedicalCondition",
"name": "Protéines morphogénétiques osseuses",
"code": {
"@type": "MedicalCode",
"code": "D019485",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.942.200"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Protéine morphogénétique osseuse de type 7",
"alternateName": "Bone Morphogenetic Protein 7",
"code": {
"@type": "MedicalCode",
"code": "D055419",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kuanxin Li",
"url": "https://questionsmedicales.fr/author/Kuanxin%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Orthopaedics, The First Affiliated Hospital of Bengbu Medical College, Laboratory of Tissue and Transplant in Anhui Province, Bengbu Medical College, Bengbu City, China."
}
},
{
"@type": "Person",
"name": "Heng Zhang",
"url": "https://questionsmedicales.fr/author/Heng%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Department of Orthopaedics, The First Affiliated Hospital of Bengbu Medical College, Laboratory of Tissue and Transplant in Anhui Province, Bengbu Medical College, Bengbu City, China."
}
},
{
"@type": "Person",
"name": "Maria Angelica Cortez",
"url": "https://questionsmedicales.fr/author/Maria%20Angelica%20Cortez",
"affiliation": {
"@type": "Organization",
"name": "Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. MACortez@mdanderson.org."
}
},
{
"@type": "Person",
"name": "Fatemeh Masrorpour",
"url": "https://questionsmedicales.fr/author/Fatemeh%20Masrorpour",
"affiliation": {
"@type": "Organization",
"name": "Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA."
}
},
{
"@type": "Person",
"name": "Cristina Ivan",
"url": "https://questionsmedicales.fr/author/Cristina%20Ivan",
"affiliation": {
"@type": "Organization",
"name": "Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Impact of Bone Morphogenetic Protein 7 and Prostaglandin receptors on osteoblast healing and organization of collagen.",
"datePublished": "2024-05-16",
"url": "https://questionsmedicales.fr/article/38753641",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0303202"
}
},
{
"@type": "ScholarlyArticle",
"name": "Potential of bone morphogenetic protein-7 in treatment of lupus nephritis: addressing the hurdles to implementation.",
"datePublished": "2023-08-25",
"url": "https://questionsmedicales.fr/article/37626268",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10787-023-01321-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predictive value of bone morphogenetic protein-7, thromboxane A2, and osteoprotegerin for prognosis of patients with distal radius fractures.",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37462630",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.52312/jdrs.2023.1043"
}
},
{
"@type": "ScholarlyArticle",
"name": "DNA methylation of bone morphogenetic protein 7 in leukocytes as a possible biomarker for hand osteoarthritis: A pilot study.",
"datePublished": "2024-08-25",
"url": "https://questionsmedicales.fr/article/39182186",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jor.25963"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cellular Response to Bone Morphogenetic Proteins-2 and -7 Covalently Bound to Photocrosslinked Heparin-Diazoresin Multilayer.",
"datePublished": "2023-05-15",
"url": "https://questionsmedicales.fr/article/37238712",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/biom13050842"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de la superfamille du TGF bêta",
"item": "https://questionsmedicales.fr/mesh/D055411"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines morphogénétiques osseuses",
"item": "https://questionsmedicales.fr/mesh/D019485"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéine morphogénétique osseuse de type 7",
"item": "https://questionsmedicales.fr/mesh/D055419"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéine morphogénétique osseuse de type 7 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéine morphogénétique osseuse de type 7",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéine morphogénétique osseuse de type 7",
"description": "Comment diagnostiquer une carence en BMP-7 ?\nQuels examens pour évaluer l'effet de BMP-7 ?\nQuels marqueurs biologiques sont liés à BMP-7 ?\nY a-t-il des tests génétiques pour BMP-7 ?\nComment évaluer l'activité de BMP-7 dans le corps ?",
"url": "https://questionsmedicales.fr/mesh/D055419#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéine morphogénétique osseuse de type 7",
"description": "Quels symptômes indiquent un problème avec BMP-7 ?\nLa carence en BMP-7 cause-t-elle des douleurs ?\nQuels signes cliniques sont associés à BMP-7 ?\nBMP-7 affecte-t-elle la cicatrisation des plaies ?\nY a-t-il des symptômes neurologiques liés à BMP-7 ?",
"url": "https://questionsmedicales.fr/mesh/D055419#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéine morphogénétique osseuse de type 7",
"description": "Comment prévenir les carences en BMP-7 ?\nY a-t-il des exercices pour soutenir BMP-7 ?\nQuels aliments favorisent la production de BMP-7 ?\nLa prévention des fractures aide-t-elle BMP-7 ?\nDes habitudes de vie influencent-elles BMP-7 ?",
"url": "https://questionsmedicales.fr/mesh/D055419#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéine morphogénétique osseuse de type 7",
"description": "Quels traitements utilisent BMP-7 ?\nComment BMP-7 est-il administré ?\nY a-t-il des effets secondaires du traitement avec BMP-7 ?\nBMP-7 est-elle utilisée en médecine régénérative ?\nQuels sont les résultats attendus du traitement avec BMP-7 ?",
"url": "https://questionsmedicales.fr/mesh/D055419#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéine morphogénétique osseuse de type 7",
"description": "Quelles complications peuvent survenir avec BMP-7 ?\nBMP-7 peut-elle causer des tumeurs ?\nComment gérer les complications liées à BMP-7 ?\nY a-t-il des complications à long terme avec BMP-7 ?\nLes complications de BMP-7 sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D055419#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéine morphogénétique osseuse de type 7",
"description": "Quels facteurs augmentent le risque de carence en BMP-7 ?\nLes maladies osseuses influencent-elles BMP-7 ?\nLe mode de vie impacte-t-il BMP-7 ?\nY a-t-il des prédispositions génétiques pour BMP-7 ?\nLe tabagisme affecte-t-il BMP-7 ?",
"url": "https://questionsmedicales.fr/mesh/D055419#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en BMP-7 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses d'imagerie peuvent aider à évaluer les niveaux de BMP-7."
}
},
{
"@type": "Question",
"name": "Quels examens pour évaluer l'effet de BMP-7 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie par résonance magnétique (IRM) et les radiographies sont souvent utilisées."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont liés à BMP-7 ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de BMP-7 peuvent être corrélés avec d'autres biomarqueurs osseux dans le sang."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests génétiques pour BMP-7 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent être réalisés pour identifier des mutations affectant BMP-7."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'activité de BMP-7 dans le corps ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études fonctionnelles et des dosages spécifiques peuvent mesurer l'activité de BMP-7."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec BMP-7 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs osseuses, des fractures fréquentes et une mauvaise cicatrisation peuvent survenir."
}
},
{
"@type": "Question",
"name": "La carence en BMP-7 cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une carence peut entraîner des douleurs osseuses et des troubles de la croissance."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à BMP-7 ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des anomalies de la croissance osseuse et des déformations squelettiques."
}
},
{
"@type": "Question",
"name": "BMP-7 affecte-t-elle la cicatrisation des plaies ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, BMP-7 joue un rôle crucial dans la régénération des tissus et la cicatrisation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques liés à BMP-7 ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes neurologiques peuvent survenir si des anomalies osseuses compressent des nerfs."
}
},
{
"@type": "Question",
"name": "Comment prévenir les carences en BMP-7 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et des suppléments peuvent aider à maintenir des niveaux adéquats."
}
},
{
"@type": "Question",
"name": "Y a-t-il des exercices pour soutenir BMP-7 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exercices de renforcement osseux et d'étirement peuvent favoriser la santé osseuse."
}
},
{
"@type": "Question",
"name": "Quels aliments favorisent la production de BMP-7 ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les aliments riches en calcium et en vitamine D peuvent soutenir la production de BMP-7."
}
},
{
"@type": "Question",
"name": "La prévention des fractures aide-t-elle BMP-7 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, prévenir les fractures peut réduire la demande sur BMP-7 pour la réparation osseuse."
}
},
{
"@type": "Question",
"name": "Des habitudes de vie influencent-elles BMP-7 ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter le tabagisme et l'alcool peut améliorer la santé osseuse et BMP-7."
}
},
{
"@type": "Question",
"name": "Quels traitements utilisent BMP-7 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "BMP-7 est utilisé dans des greffes osseuses et des traitements de fractures complexes."
}
},
{
"@type": "Question",
"name": "Comment BMP-7 est-il administré ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "BMP-7 peut être administré par injection locale ou par voie chirurgicale lors de greffes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires du traitement avec BMP-7 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets secondaires peuvent inclure des réactions inflammatoires ou des douleurs au site d'injection."
}
},
{
"@type": "Question",
"name": "BMP-7 est-elle utilisée en médecine régénérative ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, BMP-7 est explorée pour ses applications en médecine régénérative et en orthopédie."
}
},
{
"@type": "Question",
"name": "Quels sont les résultats attendus du traitement avec BMP-7 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les résultats incluent une meilleure cicatrisation osseuse et une réduction des douleurs."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec BMP-7 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des infections, des réactions allergiques et des douleurs persistantes."
}
},
{
"@type": "Question",
"name": "BMP-7 peut-elle causer des tumeurs ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un risque accru de tumeurs osseuses avec une utilisation excessive de BMP-7."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à BMP-7 ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut un suivi médical régulier et des traitements symptomatiques appropriés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme avec BMP-7 ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications à long terme peuvent inclure des déformations osseuses ou des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Les complications de BMP-7 sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares mais peuvent survenir, nécessitant une surveillance attentive."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de carence en BMP-7 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, une mauvaise nutrition et certaines maladies peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les maladies osseuses influencent-elles BMP-7 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'ostéoporose peuvent affecter la production et l'activité de BMP-7."
}
},
{
"@type": "Question",
"name": "Le mode de vie impacte-t-il BMP-7 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire et une alimentation déséquilibrée peuvent nuire à BMP-7."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques pour BMP-7 ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines prédispositions génétiques peuvent influencer la production de BMP-7."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il BMP-7 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut réduire la production de BMP-7 et nuire à la santé osseuse."
}
}
]
}
]
}
Department of Orthopaedics, The First Affiliated Hospital of Bengbu Medical College, Laboratory of Tissue and Transplant in Anhui Province, Bengbu Medical College, Bengbu City, China.
Department of Orthopaedics, The Second Affiliated Hospital of Medical College, Shihezi University, Xinjiang, China.
Publications dans "Protéine morphogénétique osseuse de type 7" :
Department of Orthopaedics, The First Affiliated Hospital of Bengbu Medical College, Laboratory of Tissue and Transplant in Anhui Province, Bengbu Medical College, Bengbu City, China.
Publications dans "Protéine morphogénétique osseuse de type 7" :
This study seeks to investigate the impact of co-administering either a Prostaglandin EP2 receptor agonist or an EP1 receptor antagonist alone with a low dose BMP7 on in vitro healing process, collage...
Human osteoblast cells were used in this study. These cells were cultured and subjected to different concentrations of Prostaglandin EP2 receptor agonist, EP1 receptor antagonist, BMP7, Control (Ct) (...
The combination of low dose BMP7 and Prostaglandin EP2 receptor agonist resulted to the lowest cell viability when compared to both the Ct and individual treatments. In contrast, the Prostaglandin EP1...
The combination of a Prostaglandin EP2 receptor agonist or an EP1 receptor antagonist when combined with low dose BMP7 significantly hinders both human osteoblast healing and collagen maturity/concent...
Up to 50% of systemic lupus erythematosus (SLE) patients world-wide develop lupus nephritis (LN). In low to middle income countries and in particular in sub-Saharan Africa, where SLE is prevalent with...
This study aims to investigate the predictive value of bone morphogenetic protein-7 (BMP-7), thromboxane A2 (TXA2), and osteoprotegerin (OPG) for the prognosis of patients with distal radius fractures...
Between January 2021 and January 2022, a total of 124 patients (71 males, 53 females; mean age: 49.8±5.1 years; range, 34 to 68 years) with distal radius fractures were included in the fracture group....
Age, fracture classification, early loss of palmar tilt, late loss of palmar tilt, time to return to exercise after surgery, BMP-7, TXA2, and OPG were all factors influencing the prognosis (p<0.05). F...
The combined detection of BMP-7, OPG, and TXA2 is highly valuable for predicting the prognosis of patients with distal radius fractures....
Hand osteoarthritis (HOA), characterized by an earlier onset age and reduced susceptibility to mechanical stress compared with knee and hip osteoarthritis, is considered a suitable disease for identif...
Despite the plethora of research that exists on recombinant human bone morphogenetic protein-2 and -7 (rhBMP-2 and rhBMP-7) and has been clinically approved, there is still a need to gain information ...
The association between bone morphogenetic protein 10 (BMP10) and atrial fibrillation (AF) has been widely investigated by observational studies, but their causal relationships remain inconclusive. He...
A Mendelian randomization (MR) analytic framework was applied to data from two BMP10-specific genome-wide association studies comprising a total of 11,036,163 single-nucleotide polymorphisms of Europe...
Specific to AF-specific genome-wide association studies, we found that BMP10 was not associated with AF among different methods (all...
This large-scale population study upon data from BMP10- and AF-specific genome-wide association studies and a longitudinal biobank cohort indicates plausible non-causal associations between BMP10 and ...
This study aimed to determine the function of angiopoietin-related protein 4 (ANGPTL4) and bone morphogenetic protein 7 (BMP7) on hepatocellular carcinoma (HCC). Overexpressing plasmids were cotransfe...
In the mid-1960s, bone morphogenetic proteins (BMPs) were first identified in the extracts of bone to have the remarkable ability to induce heterotopic bone. When the Drosophila gene decapentaplegic (...
To evaluate the effect of bone morphogenetic protein-6 (BMP-6) on transforming growth factor (TGF)-β...
Adult retinal pigment epithelial cell line (ARPE-19) were randomly divided into control, TGF-β...
Compared with the control group, the migration of RPE cells in the TGF-β...
BMP-6 prevents the EMT in RPE cells induced by TGF-β...
AMD3100, a CXCR4 antagonist, is currently prescribed for activating the mobilization of hematopoietic stem cells. Recently, AMD3100 was shown to potentiate bone morphogenetic protein-2 (BMP-2)-induced...
In vitro osteoblastic differentiation and cell migration after sequential treatments with AMD3100 and BMP-2 were analyzed by alkaline phosphatase (ALP) activity, ALP staining, and calcium accumulation...
Compared with single treatment using either AMD3100 or BMP-2 alone, sequential treatment with AMD3100 followed by BMP-2 on mesenchymal cells increased osteogenic differentiation. Application of AMD310...
Our data suggest that single or continuous injection of AMD3100 can potentiate BMP-2-induced osteoblastic differentiation and bone regeneration. This strategic combination of AMD3100 and BMP-2 may be ...